Literature DB >> 16055942

Beta-amyloid protein structure determines the nature of cytokine release from rat microglia.

Catharina Lindberg1, Maj-Linda Bardyl Selenica, Anita Westlind-Danielsson, Marianne Schultzberg.   

Abstract

Activated microglia represent a major source of inflammatory factors in Alzheimer's disease and a possible source of cytotoxic factors. beta-Amyloid (Abeta) peptide, the predominant component in amyloid plaques, has been shown to activate microglia and stimulate their production of inflammatory factors. The present study was performed to analyze the responses of microglia to different forms of Abeta, with regard to release of the proinflammatory cytokines interleukin-1alpha (IL-1alpha), IL-1beta, tumor necrosis factor-alpha (TNF-alpha), IL-6, and interferon-gamma (IFN-gamma), as well as the IL-1 receptor antagonist (IL-1ra). Primary cultures of microglia from rat neonatal cerebral cortex were incubated with freshly dissolved Abeta1-40 or Abeta1-42, Abeta1-40 fibrils, Abeta1-40 betaamy balls, or vehicle. Abeta1-40 fibrils did not significantly stimulate any of these cytokines. Freshly dissolved Abeta1-40 resulted in a marked increase in the release of IL-1beta, and freshly dissolved Abeta1-42 significantly stimulated both IL-1alpha and IFN-gamma secretion. The Abeta1-40 betaamy balls stimulated the secretion of IL-1alpha and IL-1beta. Incubation with Abeta peptides did not affect the secretion of IL-1ra, IL-6, or TNF-alpha. In the case of IL-1beta, the response is correlated with the presence of Abeta peptide as monomers and oligomers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16055942     DOI: 10.1385/JMN:27:1:001

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  74 in total

Review 1.  Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease.

Authors:  Dennis J Selkoe
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

Authors:  Hai-Wei Wang; Joseph F Pasternak; Helen Kuo; Helen Ristic; Mary P Lambert; Brett Chromy; Kirsten L Viola; William L Klein; W Blaine Stine; Grant A Krafft; Barbara L Trommer
Journal:  Brain Res       Date:  2002-01-11       Impact factor: 3.252

3.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  Oxidation of methionine 35 attenuates formation of amyloid beta -peptide 1-40 oligomers.

Authors:  Magnus Palmblad; Anita Westlind-Danielsson; Jonas Bergquist
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157

5.  Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

Authors:  D Blum-Degen; T Müller; W Kuhn; M Gerlach; H Przuntek; P Riederer
Journal:  Neurosci Lett       Date:  1995-12-29       Impact factor: 3.046

6.  Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices.

Authors:  J Bauer; S Strauss; U Schreiter-Gasser; U Ganter; P Schlegel; I Witt; B Yolk; M Berger
Journal:  FEBS Lett       Date:  1991-07-08       Impact factor: 4.124

7.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

Authors:  D M Walsh; A Lomakin; G B Benedek; M M Condron; D B Teplow
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

8.  Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia.

Authors:  D Giulian; L J Haverkamp; J H Yu; W Karshin; D Tom; J Li; J Kirkpatrick; L M Kuo; A E Roher
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

9.  Scavenging of Alzheimer's amyloid beta-protein by microglia in culture.

Authors:  M D Ard; G M Cole; J Wei; A P Mehrle; J D Fratkin
Journal:  J Neurosci Res       Date:  1996-01-15       Impact factor: 4.164

10.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Authors:  W S Griffin; L C Stanley; C Ling; L White; V MacLeod; L J Perrot; C L White; C Araoz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

View more
  30 in total

Review 1.  Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain.

Authors:  Yasuhiro Suzuki; Qila Sa; Marie Gehman; Eri Ochiai
Journal:  Expert Rev Mol Med       Date:  2011-10-04       Impact factor: 5.600

2.  Cytokine production by a human microglial cell line: effects of beta-amyloid and alpha-melanocyte-stimulating hormone.

Authors:  Catharina Lindberg; Erik Hjorth; Claes Post; Bengt Winblad; Marianne Schultzberg
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

3.  Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity.

Authors:  Izumi Maezawa; Pavel I Zimin; Heike Wulff; Lee-Way Jin
Journal:  J Biol Chem       Date:  2010-10-22       Impact factor: 5.157

Review 4.  Anesthetic modulation of neuroinflammation in Alzheimer's disease.

Authors:  Junxia X Tang; Maryellen F Eckenhoff; Roderic G Eckenhoff
Journal:  Curr Opin Anaesthesiol       Date:  2011-08       Impact factor: 2.706

5.  IL-33 is induced by amyloid-β stimulation and regulates inflammatory cytokine production in retinal pigment epithelium cells.

Authors:  Xiao-Cui Liu; Xiao-Fei Liu; Cong-Xiang Jian; Chen-Jun Li; Shou-Zhi He
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

6.  Amyloid-β-induced astrocytic phagocytosis is mediated by CD36, CD47 and RAGE.

Authors:  Raasay S Jones; Aedín M Minogue; Thomas J Connor; Marina A Lynch
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-14       Impact factor: 4.147

7.  The effects of repetitive stress on tat protein-induced pro-inflammatory cytokine release and steroid receptor expression in the hippocampus of rats.

Authors:  Khayelihle B Makhathini; Oualid Abboussi; Musa V Mabandla; William M U Daniels
Journal:  Metab Brain Dis       Date:  2018-07-10       Impact factor: 3.584

Review 8.  Inflammatory mechanisms in neurodegeneration.

Authors:  Michael R Nichols; Marie-Kim St-Pierre; Ann-Christin Wendeln; Nyasha J Makoni; Lisa K Gouwens; Evan C Garrad; Mona Sohrabi; Jonas J Neher; Marie-Eve Tremblay; Colin K Combs
Journal:  J Neurochem       Date:  2019-03-27       Impact factor: 5.372

9.  Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease.

Authors:  Malabendu Jana; Carlos A Palencia; Kalipada Pahan
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

10.  Effects of immunomodulatory substances on phagocytosis of abeta(1-42) by human microglia.

Authors:  Erik Hjorth; Dan Frenkel; Howard Weiner; Marianne Schultzberg
Journal:  Int J Alzheimers Dis       Date:  2010-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.